THE SAVINGS
Chronic wounds represent a major financial strain on the U.S. healthcare system. A comprehensive analysis of Medicare claims found that wound care costs were $28.1 to $31.7 billion annually, placing chronic non-healing wounds among the top five most costly health conditions treated by Medicare (Nussbaum et al., Value in Health, 2018). This economic burden rivals that of heart disease, cancer, and other leading drivers of healthcare spending.
These costs often reflect ongoing management rather than healing. Extended hospitalizations, repeat admissions, and procedures such as amputations drive expenses upward while leaving patients with diminished quality of life.
As one physician put it: “It costs our healthcare industry a tremendous amount of money to leave patients with chronic non-healing wounds and not pursue aggressive measures to heal them.”
Skin substitutes, or Cellular and Acellular Matrix Products (CAMPs), offer a way forward by preventing the prolonged cycles of treatment that make wound care so expensive. Faster healing translates into fewer admissions, shorter hospital stays, and reduced risk of complications such as infection, sepsis, and amputation.
The benefits extend across the system:
-
Patients face fewer hospital visits and reduced out-of-pocket costs.
-
Hospitals see improved healing rates, lower readmissions, and better outcomes for their patients.
-
Medicare and Medicaid can curb billions in annual spending by shifting from prolonged wound management to definitive healing.
The evidence points toward a simple truth: when wounds are healed rather than endlessly managed, patients live better lives — and the healthcare system saves money.
.jpg)
CAMPAIGN NAME
EXPERIENCED RESULTS
DRIVEN LEADERSHIP
2035